Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Elacridar (GF120918) | 143664-11-3 | MFCD00912604 | 99.7% | C34H33N3O5 | 100 MG
Supplier: Medchemexpress LLC HY50879100MG
Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. It can be utilized to investigate the influence of efflux transporters on agent distribution to the brain and in cancer research. This product is for research use only.
- Inhibits P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP)
- Utilized to examine efflux transporters on agent distribution to the brain
- Used in cancer research
- Affects P-glycoprotein and ABCG2 protein expression levels
- Impacts 99mTc-MIBI intracellular accumulation
- Shows differential distribution in brain and plasma
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?